Thorne Healthtech, Inc.
THRNDelisted Oct 16, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001844280
Thorne Healthtech, Inc. was delisted on Oct 16, 2023; its insiders filed their last Form 4 on Oct 18, 2023; 59 institutions reported holding it in 13F filings for Q3 2023, worth $82.9M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Thorne Healthtech, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 45 | 44 | −1 |
| Shares | 4.78M | 4.78M | +433 (0.0%) |
| Value | $17.4M | $22.1M | +$4.74M (+27.3%) |
New holders (7)
Institutions that held Thorne Healthtech, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Royce & Associates LP | 134,300 | $620.5K | 0.01% |
| Bridgeway Capital Management, LLC | 69,900 | $322.9K | 0.01% |
| Susquehanna International Group, LLP | 17,744 | $82.0K | 0.00% |
| Wells Fargo & Company | 2,682 | $12.4K | 0.00% |
| TCI Wealth Advisors, Inc. | 478 | $2.21K | 0.00% |
| Ellevest, Inc. | 61 | $282 | 0.00% |
| Nisa Investment Advisors, LLC | 33 | $0 | 0.00% |
Sold out (8)
Institutions that held Thorne Healthtech, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Rockefeller Capital Management L.P. | 82,200 | $298.0K |
| Scout Investments, Inc. | 61,237 | $222.3K |
| Atria Wealth Solutions, Inc. | 40,200 | $145.9K |
| Ameriprise Financial Inc | 31,368 | $114.0K |
| Millennium Management LLC | 30,068 | $109.0K |
| Invesco Ltd. | 12,981 | $47.1K |
| US Bancorp | 2,000 | $7.26K |
| Credit Suisse AG | 1 | $4 |